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ABSTRACT (261 words) 
 
Background: Bacterial skin and soft tissue infections (SSTI) among people who inject drugs (PWID) 
are considered a public health concern. There is a lack of qualitative research examining the lived 
experience of PWID  who have had SSTI.  This paper explores PWID views and experiences of their 
SSTI, their perceptions on the causes of their SSTI and their harm reduction (HR) behaviours. The 
implications for HR service delivery and practice will be discussed. 
 
Methods: Between October 2015-January 2016, 22 in-depth interviews were conducted with PWID 
who had experienced a SSTI within the past year.  Interviewees were recruited from an injecting 
equipment provision service and a drug treatment service in Glasgow and Edinburgh respectively. 
The interview transcripts were transcribed verbatim and underwent thematic analysis. 
 
Results: We found that the experience of SSTI can cause strong negative feelings, including panic 
and stigma and that there was limited knowledge of SSTI prior to first hand experience. The 
awareness of the unacceptable social and physical consequences of SSTI fostered a sense of 
personal responsibility and agency which led to the introduction or improved HR uptake. However, 
when PWID were struggling to inject or when their physical and political environments were 
compromised there was an increased risk for SSTI and reduced effectiveness of HR. 
 
Conclusion: Compared to HCV and HIV, SSTI as an injecting related harm has received less policy 
attention. Policy makers need to address SSTI HR within enabling environments, such as ‘safer 
environment interventions’. It is recommended that peer based support, improved NSP provision and 
medically supervised injecting facilities are needed to deliver SSTI HR. 
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INTRODUCTION 
 
Skin and soft tissue infections (SSTI) among people who inject drugs (PWID) are considered a public 
health concern. Injection site SSTI are typically caused  by bacteria on the skin from unsterile injecting 
equipment or contaminated drugs (Gordon & Lowy, 2005). If these infections, which typically result in 
abscesses or cellulitis, are left untreated they can result in serious morbidity and mortality; in addition, 
infections (such as anthrax and botulism) caused by spore forming bacteria (SFB) can be fatal 
because of the toxins produced and require prompt medical attention (Hope, 2010). 
 
A systematic review of international prevalence studies has shown that SSTI are common among 
PWID; between 6 to 32% of PWID reported a  current  SSTI  or having had one within the past month, 
and 7 to 37% reported an SSTI within the past  6 to 12 months (Larney, Peacock, Mathers, Hickman, 
& Degenhardt, 2017). Despite this, much of the harm reduction (HR) aimed at PWID has arisen from, 
and remains focussed on, the prevention of HCV (Hepatitis C virus) and HIV leaving SSTI as the 
neglected injecting related harm (Hope, 2010). 
The growing body of literature on SSTI among PWID has been dominated by quantitative cross 
sectional studies, aimed at identifying risk factors associated with SSTI prevalence, and clinical case-
reports.  These studies have identified a  number  of risk factors: including being female, frequent 
injecting, and intra-muscular or subcutaneous injecting; whilst skin swabbing and hand washing were 
identified as protective factors (Larney et al., 2017). A limited number of behavioural change 
intervention studies have examined SSTI; including brief interventions addressing injection site 
cleaning, hand cleaning or needle bleaching (Mercure, Tetu, Lamonde,
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& Cote, 2008; Phillips, Stein, Anderson, & Corsi, 2012). However, HR behaviours learned through 
such brief interventions may become irrelevant within the  everyday life of a PWID (Miller, 2005). 
Studies examining the impact of structural interventions, such as injecting equipment provision, on 
SSTI have also been limited and quantitative in design (Larney et al., 2017).  Although these 
quantitative studies highlight the associations between risk or protective factors and SSTI, qualitative 
studies are needed to help understand the many explanations within the PWIDs’ within NHS Greater 
Glasgow and Clyde Health Board. These research sites were chosen as these Health Boards have 
sizeable injecting populations and unpublished survey data indicated the proportion of PWID reporting 
an SSTI in the past year was 36% and 27% respectively (unpublished University of the West of 
Scotland & NHS Health Protection Scotland Needle Exchange Surveillance Initiative (2013) data). 
These areas had also recently experienced clusters/outbreaks of bacterial infections. Within NHS 
Greater Glasgow and Clyde there was a  botulism  cluster/outbreak  during Dec 2014-July 2015 (NHS 
National Services Scotland, 2017) and in NHS Lothian there was a Group A Streptococcus 
cluster/outbreak associated with ethylphenidate, a new psychoactive substance (NPS) during 2014-
2015 (Yeung et al., 2017). 
 
Sampling and recruitment 
 
Staff at the research sites facilitated recruitment by initially informing their clients  about the study and 
the availability of the researcher. The researcher explained the nature of the study to possible 
participants and  checked  eligibility.  Eligible participants were those who were 18 years or older, had 
injected in the past six months and had experienced a SSTI within the past year. SSTI were defined 
as abscesses, cellulitis or necrotising fasciitis caused by injecting. Photographs of localised SSTI 
symptoms and descriptions of local and systemic  symptoms  were used to help identify the nature of 
the SSTI experienced. Purposive sampling was  used to recruit PWID by SSTI and by gender. 
Exclusion criteria included those  younger than 18 years. 
 
Data collection 
In-depth interviews, lasting between 21 and 67 minutes, were undertaken in a private consulting room 
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at the recruitment sites between October 2015 and January 2016. A short questionnaire was used to 
gather non-identifiable demographics, drug use and opiate substitution treatment history within the 
past six months. A topic  guide  explored PWID’s experiences and views of SSTI including 
clusters/outbreaks of SFB infections, how they responded to their infection in terms of HR, healthcare 
seeking and self-treatment. The interview focussed on the most recent and/or most severe SSTI 
experienced. 
 
Analysis 
 
All interviews were digitally recorded, transcribed verbatim and  pseudonyms assigned. The 
transcripts were categorised thematically using framework analysis (Ritchie, Lewis, McNaughton 
Nicholls, & Ormston, 2014). Framework analysis, which consists of data management and data 
analysis is a useful technique for the formulation of policy (Tim Rhodes & Coomber, 2010; Ritchie et 
al., 2014). 
 
Microsoft WORD was used to manage the data. The lead author checked the transcripts and 
recordings for accuracy and familiarisation of the data, developed the initial framework by applying the 
topic guide to create categories to help sift and sort the data. The study team agreed the coding 
framework. The lead author  indexed  each transcript using these framework categories. Matrices 
were developed for each framework category where the participants’ interviews were summarized 
within the matrix. This enabled analysis of a category across all participants or analysis across the 
categories by a single participant. Data  analysis consisted of  mapping the range of responses and 
looking for patterns in the matrices and links between categories. 
 
From this a number of themes emerged including: impact of SSTI; knowledge  of  SSTI; personal 
responsibility and agency; social and physical risk environment. Rhodes’ theory of risk environment 
was used to help interpret and explain  the  findings to aid a policy level discussion on the need and 
direction for SSTI HR interventions (Tim Rhodes, 2002, 2009). The ‘risk environment’ framework 
enables an examination of the physical, social, economic and political environments that influence 
injecting practices and disrupt HR uptake.  These four dimensions operate at a micro and macro level. 
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The ‘risk environment’ shapes the success or failure of HR interventions (Tim  Rhodes, 2002). 
Descriptive statistics were used to describe the participants’ demographics. 
 
Ethics 
 
NHS West of Scotland Research Ethics Committee and the University of the West of Scotland Ethics 
Committee granted ethical approval. Participants were given an information sheet and provided 
informed consent prior to data collection. Participants were offered a £25 retail voucher for their time. 
 
 
FINDINGS 
 
Participant characteristics 
 
Twenty two PWID were interviewed between Glasgow (n=14) and Edinburgh (n=8). The median age 
was 36.5 years (range 21 to 61 years), 68% (15) were male and 59% (13) had experienced 
homelessness during the past six months.  They had been injecting for a median of 15.5 years (range 
5 to 43 years). All participants had injected heroin within the past six months, for 82% (18) this was 
the main drug injected; for one participant cocaine was their main drug, and for another one it was 
NPS and heroin equally taken. The majority (82%, 18) were injecting at least daily. Between all 
participants, a total of 23 abscesses, three cellulitis and two necrotising fasciitis infections were 
experienced in the past year. 
 
Impact of SSTI 
 
SSTI typically caused many strong negative feelings among the majority of participants whilst only a 
few participants felt unconcerned. 
 
Dave, for example, who had experienced abscesses intermittently over the past 25 years, showed no 
concern for abscesses, describing SSTI to be an inevitable consequence of injecting: 
It’s all part and parcel of, it’s just a, another sort of hazard a’ drug taking.  (Dave, Male, 40 
year old) 
This suggests that some PWID normalise SSTI. However, this view that injecting related harm, such 
as abscesses, is normal or inevitable (Morrison, Elliott, & Gruer, 1997) belies the strong negative 
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psychological suffering that can be experienced by PWID with SSTI. In contrast to Dave’s unconcern, 
others felt panicked or stigmatised by the symptoms. 
Feelings of panic were linked to physical consequences such as a fear of losing a  limb, which was a 
commonly held view, or from lack of healing and  potential  poisoning of the body. Fear of losing a 
limb was illustrated by Brian who had cellulitis: 
I What is it about it that – what is it that makes you worry about it? 
 
R Just the infection an’ everything. Do you know what I mean? Because you 
don’t know what it could beYou might end up losing a limb. (Brian, Male, 42 years old)  
 
In addition to the fear of the possible physical outcomes of SSTI, PWID also felt stigmatised by them. 
This stigma could be internalised, as demonstrated by Holly: 
And I feel conscious about it and I hate myself for it. So it makes me feel, it makes me feel 
horrible.  Ugly and horrible and, you know.  It’s no nice.  But   it’s self inflicted, but it’s ma own 
fault, you know. (Holly, Female, 36 years old) 
 
But, like HCV and HIV, which stigmatise PWID by association with injecting (Treloar & Rhodes, 2009), 
SSTI were also socially stigmatising, but in a much more visual way, by potentially identifying a PWID 
because of the unsightly visible physical symptoms: 
But see when I’ve got poison in them an’ they’re green an’ yellow an’ that, you dinnae like 
any, naebody tae [you don’t like anyone to] actually see that. It’s horrible, it’s like a deformity 
on you [A]s if somebody would go, “Aye, you can tell he’s jagging.  Look, you can tell he’s 
injecting drugs because look at  his legs.” it stops you fae wearing shorts or things like that 
on a hot day or whatever, eh? (Danny, Male, 43 years old) 
 
 
Knowledge of SSTI 
 
Concern, or lack of it, about the physical aspects of SSTI appeared to be linked to level of knowledge 
about SSTI. Dave, mentioned above as showing no concern, had gained knowledge from having had 
abscesses over 25 years: 
I knew a fair lot cause I had a fair few [laughs]. (Dave, Male, 40 year old) 
And Alison, who was also unconcerned about her abscess, had gained awareness from seeing or 
hearing about abscesses from her social network: 
I wasn’t overly worried about it because I knew that it was acting as the same way as ma 
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other friends. (Alison, Female, 36 year old) 
In contrast, among some PWID there was very little second hand learning of SSTI from peers: 
I’d seen folk wi’ them and that eh. But I just never knew anything aboot them eh. (Bobby, 
Male, 32 year old)   
 
My ex boyfriend, he had an abscess. [I] Never ever looked at it. But he was always on about 
abscess[es]. I didnae [did not] ask him any questions or anything like that. Just…but aye and 
then I got one maself. (Tanya, Female, 21 years old) 
Consequently, those who experienced a SSTI for the first time demonstrated a lack    of knowledge as 
exemplified by Allan, who had been injecting for 16 years before experiencing his first abscess: 
I didn’t know anything about them until it happened. … Until I got, [NAME of FRIEND] knew 
about them but he didn’t tell me until something happened. … Cause I, I asked him. I was 
like, ‘what the hell’s that on my arm?’ He’s like, ‘it’s an abscess’. (Allan, Male, 34 year old) 
A lack of second-hand learning from other peoples’ experiences reflected a disinterest until SSTI 
became relevant: 
Ken, it was nowt tae dae wi’ me [Do you know what I mean, it was nothing to do with me], 
until I started getting them an’ then I started realising “Oh here, he must have got that through 
the… here mate, how did you get that?” Aye, it’s just I’ve got one there an’ you can, 
sometimes you compare, eh? (Danny, Male, 43 years old) 
For some this disinterest arose from  a belief that they would never suffer from a SSTI as illustrated by 
Bobby: 
Aye that’ll never happen tae me.   I had the attitude, that was the attitude I  had. ‘That’ll never 
happen tae me’. I’m the lucky one and that, it’ll no happen tae me (Bobby, Male, 32 years old) 
Interestingly, Bobby was unwilling to share his experience of his groin abscess with his social 
network, an approach which helps explain a lack of second-hand learning: 
I didnae [I didn’t] like talking about mine because it was all self inflicted eh. It was all really my 
fault. So it was like that’s ma business eh (Bobby, Male, 32 years old) 
 
The above shows that for some PWID, learning about SSTI was gained from personal experience 
whilst others gained awareness from their peers. 
 
The experience of, and learning gained from having a SSTI can also leave some PWID, such as 
Allan, viewing SSTI as an experience not to be repeated: 
I don’t want another abscess, trust me. The pain was excruciating. (Allan, Male, 34 year old) 
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Personal responsibility and agency 
 
Awareness of the unacceptable social or physical consequences of SSTI fostered a sense of personal 
responsibility and agency in some PWID which, in turn, encouraged wound care or the use of HR 
techniques to avoid future infection. However, whilst it was commonplace for HR to be introduced or  
used  more  frequently since a SSTI, some PWID did not consciously associate this with addressing 
SSTI or they considered SSTI to be unpredictable: 
But see, see to tell you the truth, you, you don’t, you dinnae [didn’t]  even really know when 
you’re gonnae [going to] get them because one time you could get yourself in the vein and it 
can turn intae an abscess. Or another time you can miss and it doesnae turn intae [does not 
turn into] an abscess. Another time you can miss and it does turn intae an abscess. (Amy, 
Female, 34 year old) 
 
Dave, who considered the unsightly symptoms as socially unacceptable, was prepared to look after 
his abscesses, indicating a level of personal responsibility and awareness of the need to manage and 
minimise any symptoms: 
They don’t bother me because I don’t let them get…I don’t let them get out a’ control. I know 
people and they do nothing about them. And they’re stinking and it’s, it’s horrible. And there’s 
no need for it. Well I, I use antiseptic swabs morning, noon and night. I dress them meself wi’ 
iodine and…and patch [bandages] Yeah, yeah but if it gets too bad I’ll go tae a doctor and 
get a course a’ antibiotics and then, or else he’ll slit it or taken intae a hospital, depending on 
how bad it is or where on the body is it. (Dave, Male, 40 year old) 
Many participants practiced skin swabbing. Brian, who had been hospitalised with cellulitis, engaged 
in consistent swabbing to help avoid another infection: 
Well, like I said, I’m swabbing mair [more]. Do you know what I mean? To make sure that it’s 
no’ happening. It’s the last thing I want. I dinnae [don’t] want that again. Naebody [Nobody] 
wants it. (Brian, Male, 42 years old) 
And, as noted by Patricia, the provision of swabs in the ‘one hit kits’ (a pack  containing a sterile N/S, 
spoon, filter, wipe/swab and citric acid sachet for a single injection) was beneficial: 
‘Cause especially wi’ the one hit kits now. Like, before when you got your tools, … probably a 
Sterex wasnae the first on your – you know, you wouldnae [would not] really think ‘Oh, I need 
a Sterex.’ But when it’s in the one hit kit and it’s there for you to use, I think you’re more likely 
to use it, you know? (Patricia, Female, 34 years old) 
However, despite the supply of swabs in the ‘one hit kits’, they were not always used for the intended 
purpose: 
Getting them quite regular. Always making sure that I’ve got new, new clean needles and 
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swabs. A’, a’ the paraphernalia, the cookers, everything. But one a’ the things that I didnae 
dae [didn’t do] and I should have done during ma using was the swabs. I didnae clean maself 
often enough before I, before I had the injection. … But it’s like another thing, you know, 
because you’ve got about ten things tae dae [to do] before you actually get the hit. And it’s 
building up and building up, a’ the excitement, everything.   And then so I’ll just say the less  
work [to] get this hit, get this. (Sam, Male, 49 year old) 
John used his wipes to clean the injecting equipment and to get a better flame: 
 
Just maybe cleaning my pot, or if my lighter’s no’ very good, lighting the swab because that’s 
got alcohol in it and gies [gives] you a flame tae [to] cook the hit up. (John, Male, 45 years 
old) 
A few participants noted that pre-injection wipes were not necessary as they showered or bathed 
before injecting to help them locate surface veins. Others would use baby wipes or alcohol wipes 
post-injection rather than pre-injection. 
 
Other HR introduced following a SSTI included: improved general cleanliness, staying away from 
squalid injecting settings, taking time to inject to avoid missing, keeping to surface veins by using 1ml 
N/S to avoid digging for deeper veins, using a sterile needle for each attempt, increasing the quantity 
of injecting equipment collected from a NSP (for example, from 10-20 N/S to a box of 100 N/S), 
reducing injecting frequency, regularly getting injecting wounds checked by a nurse, and abstaining 
from groin injecting or NPS. Notably, some injecting changes made would be ineffectual or counter-
productive, such as, boiling the drug solution more to remove black flecks or using more citric acid. 
 
Also, a transition to smoking was undertaken by some. Allan transitioned to smoking to reduce his 
injecting frequency and to allow his abscess to heal: 
But I’ve sorta stopped going into my arms just to let them heal. I’m smoking now at the 
moment. But I…I…I’m not gonna [going to] lie to you, I miss injecting too much. I miss the 
high of the injection. (Allan, Male, 34 year old) 
Later on in the interview, he admitted to occasionally injecting into the veins in his hand. However, 
Patricia, who had transitioned to smoking since getting an upper arm abscess, acknowledged this was 
because of the difficulty getting a vein rather than avoiding a SSTI per se. For some, smoking or 
snorting was not an option because of poor quality heroin, injecting being better and more cost 
effective, lung problems, and sharing drugs with another injector. 
 
It was rare for participants to practice injection site rotation prior to or since their SSTI. The same 
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injecting site was re-used to ensure another successful hit as explained by Eric and Liam: 
…if you have success with the hands from the previous time, that’s what I would go for the 
next time because I thought “Well, it worked the last time.” … cause veins do not pop up very 
much, it’s difficult to even see them, never mind actually hit them. (Eric, Male, 61 years old) 
…cause I got it the last time and I, I know sort of what angle to go in at. Some  a’ them could be quite 
a bit deep under the skin, yeah. (Liam, Male, 36 years old) 
Furthermore, Liam explained that he was unaware of injection site  rotation  and  would re-use the 
same vein until it was damaged before moving onto another vein: 
See I didn’t realise that site rotation was so important when I started injecting. And to be 
honest when I first started injecting, my, my main goal was suicide really, yeah. And 
but…yeah I would always use one vein until it, it was damaged and then move on to the next. 
… Then I  got to the point where I was lucky if I found one. (Liam, Male, 36 years old) 
However, Pete, who despite been advised by a friend to practice injection site rotation, justified not 
doing so because he did not want to use alternative injecting  sites that he could not conceal and thus 
avoid social stigma: 
I Okay. So, why always go in the same [injecting body site]?  
R I don’t know. I think it was just so I didnae [didn’t] get track  marks up and doon my 
airms [down my arms]. … Well, when I – when I first started injecting, my mate telt me ‘a’ways 
go, dae it here once, there once, there, just dae a box’ [my mate told me always do it here 
once, there once, there, just do a box} [PARTICIPANT POINTED TO LOWER RIGHT AND 
LEFT ARM]. So, if I dae that I’m gie’in myself [So, if I do that I’m giving myself] a chance to 
heal. … And I’ll no’ end up wi’ marks. But I was dae’in [doing it] it that much then I had a mark 
here, here, here, and here, and I looked like a pure state. (Pete, Male, 28 years old)  
For some, such as Patricia, not being aware of and not practising injecting site rotation was a cause of 
regret: 
“… I just wish I had rotated my veins more. And I wish I was more  aware of it when I first 
started injecting. You know? I’d have probably done it. ‘Cause I did have good veins at one 
time but they’ve packed in now.” (Patricia, Female, 34 years old) 
 
Personal responsibility for SSTI was also seen in the reasons PWID gave for developing these 
infections. Many participants blamed their  own injecting technique, or lack of it. 
 
Missing the vein was cited as a cause of SSTI through struggling to inject into damaged veins or from 
a lack of confidence in technique as noted  by Allan who had an abscess in the crook of his arm: 
Yeah a missed hit but I think, but the thing is I’m not the best hitter. I’m no gonnae lie tae you 
right [I’m not going to lie to you]. I’m not the greatest hitter. . . . but now my veins…are paying 
the price for it, I think. You know, now cause I’ve been missing it a lot. It’s like I’m really 
starting…tae get scared aboot it [to get scared about it] (Allan, Male, 34 year old) 
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Or from shaky hands as noted by John: 
 
Sometimes I dinnae [didn’t] have the needle right in, like against my skin and the needle 
might be out a bit when I find the vein, so, I’ll try and hold it in that position. But it depends, 
you know, shaky hands   and stuff like that. You end up missing at times. (John, Male, 45 
years old) 
Reliance on assisted injecting was also implicated for causing missed hits by Patricia and Danny who 
both noted that the assisting injector can be careless, inexperienced, unaware they have caused a 
problem or impatient to get their own hit. This can even be an issue when the person assisting was 
trusted: 
I thoroughly believe that the person was genuinely trying to get me, but unfortunately they 
missed. Right? But they’re in, maybe they’re  in a  rush for their ain stuff, or maybe whatever. 
Maybe just lack o’  knowledge o’ trying tae get it right an’ they’ve inadvertently burnt me   an’ 
caused the abscess. It’s gottae be people I know an’ people I 
have, I can trust. But even people you trust, you can still end up with abscesses an’ such like. 
(Danny, Male, 43 years old) 
 
Although struggling to inject was not always given as an explanation for their SSTI, it was a recurrent 
theme raised during descriptions of injecting experiences. Eric described deliberate muscle popping: 
Sometimes if I just haven’t been able to get a vein after, say, three tries, I’ll just put it into 
muscle. (Eric, Male, 61 year old) 
Struggling to inject resulted in some PWID resorting to surface veins or central veins, such as the 
groin. 
 
Groin injecting was commonplace and was associated with practical injecting difficulties. Caroline, 
who had a groin abscess, in general guessed whether she had hit the femoral vein and acknowledged 
she probably misses. Similarly, Tanya, who had been hospitalised for a groin abscess and DVT, 
noted that despite injecting into her groin she did not know what she doing: 
Well ma ex, he was the one that marked me. I just seen the hole and thought I could go intae 
it [into it]. And didnae [didn’t] realise what I was doing. I was hitting a nerve, artery, punctured 
ma artery. Ended up wi’ DVT, everything. Just using blunt needles, using used tools, using wi’ 
other people. (Tanya, Female, 21 years old) 
In addition, struggling to inject resulted in injecting equipment supplies being quickly depleted: 
It’s too much trouble you can spend ower an hour over mair just tae [over an hour, over more 
just to] get it. And then you could have five sets to start with and you end up getting, you’re on 
the last one. (Hugh, Male, 53 years old) 
Depletion of injecting equipment could lead to re-use of needles, seen as a cause of SSTI by some 
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participants. 
 
Needles were re-used because of lack of time or inability to replenish supplies due, for example, to 
weekend closing of convenient NSP or if they woke in the middle of the night: 
A chaotic life situation that I was in at the time, that I had to re-use because there isnae [isn’t] 
really any excuse for it, there’s exchanges everywhere in [NAME of CITY], do you know what 
I mean? And there’s a 24 hour one … Aye, so, there’s really no excuse for – but maybe time. 
Like, if it’s early hours and, you know, if you’re using, if you’ve woke up and it’s, like, half one 
or whatever and you’re gonnae [going to] have a charge then you’ve ran out of tools or 
whatever then, like, you just think ‘Ach, I’ll use that one I used earlier. (Patricia, Female, 34 
years old) 
The tendency was to re-use needles and syringes (N/S) twice or three times, with some 
acknowledgment that the needles were probably barbed, had not been cleaned or only rinsed, and 
had been taken out of a ‘cin-bin’ (incineration bin used  for the safe disposal of sharps) or a bag as 
described by Tanya: 
Needles, couldn’t be bothered walking to [NAME of EXCHANGE] because a’ the pain I was 
in. I just went to the cin-bin [sharps bin] and took, took a few used, and some a’ them were 
barbed.  I didn’t know what a barbed was cause  I never got told. (Tanya, Female, 21 years 
old) 
 
However, Sam who admitted to re-using the same needle up to 10 times, acknowledged that a 
photograph of a barbed needle, displayed in a drug treatment centre, had impact: 
I Did you know [about barbed needles]?  
R No, I forgot. No I didnae [didn’t] know that it was as bad as that photae. And when I seen that 
photae, how a needle looks when blunt, I was like, ‘what!’. Didnae [didn’t] know that. That’s, 
that’s  a, that is a pure absolute cracking photae.  You know, it’s amazing that photae. If I’d 
have seen that years and years ago I woulda’ definitely have thrown them things away.  
(Sam,  Male, 49 years old)  
Reasons for re-using,  despite picking up plenty of N/S, included had given them away to others or 
had been accidentally supplied with the wrong sized needles and preferring to re-use than use the 
wrong needle. Re-using one’s own N/S  is  considered protective against N/S sharing (Rhodes, Davis, 
& Judd, 2004) but may not prevent vein damage and the development of SSTI. 
 
Social and physical environment risks 
 
Some SSTI risks were out-with the individual control or personal agency of PWID.  For example, drug 
composition constitutes a physical/pharmacological risk environment over which PWID have no 
control (Elliott et al, 2018; McGowan et al, 2017). Some PWID believed that the drug or adulterants 
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had caused their SSTI because the drug did not look right, they generally practised safe injecting or 
they had used a different dealer from their usual. In particular, NPS injecting was implicated as the 
cause of SSTI by some participants. Danny, who had experienced abscesses whilst injecting NPS, 
noted its ‘corrosive’ effect on the skin because of ingredients such as ‘draining fluid’ or ‘oven cleaning 
fluid’ and Mike considered: 
It’s chemicals inside the legal highs, I think. It’s all it could be. Never had anything like that wi’ 
heroin so it’s a chemical inside the legal highs. It’s gotta [got to] be. (Mike, Male, 33 years old) 
 
However, a squalid physical risk environment, was also described by those injecting NPS, which 
could be implicated as causing SSTI. The most commonly injected NPS in Lothian at the time of the 
study was ‘Burst’ which contained the stimulant ethylphenidate (Lafferty et al, 2016). Pete described 
his experience whilst injecting ‘Burst’. 
In the place I was sitting, ‘cause some o’ the places I was sitting when  I was on that Burst 
were nae better than Trainspotting. … Bloody swabs all aboot the place, uncapped needles, 
cin-bins [sharps bins] - unused dirty works and in juice bottles. … It was like sitting in the kerb 
doon near the rubbish. (Pete, Male, 28 year old) 
Furthermore, Pete acknowledged sharing N/S whilst injecting Burst, suggesting that his previously 
established HR practice was being hindered: 
R But, see wi’ heroin? Wi’ heroin, you didnae [didn’t] bother, if you couldnae [could not] get 
a needle, you didn’t [inject], you went withoot [without]. But wi’ this stuff [Burst], it was 
unbelievably addictive. 
I Right. 
R An’ it was really, really bad. You didnae care, you didnae bother and it didnae matter if 
the blood, the barrel was see-through or it was bright pink, bright red. It was, it was in the 
blood, you ended up taking it. Ken [Do you know what I mean}, it was disgusting, what 
[BURST] would actually dae to your heid [do to your head]. 
I Aye. Aye. 
R Ken [Do you know what I mean] ‘cause they usually tell you 
that’s wrong, dinnae dae [don’t do it] it, wi’ heroin. But this stuff, you just – you switched off. 
(Pete, Male, 28 years old)  
 
 
DISCUSSION 
 
Our study is one of the few qualitative studies to have explored PWID views and experiences of their 
SSTI, perceived causes of SSTI and use of HR. A number of themes emerged including: impact of 
SSTI, knowledge of SSTI, personal responsibility and agency, and the social and physical risk 
environment. We found that the experience of SSTI can cause strong negative feelings, including 
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panic and stigma and that there was limited second hand learning from peers about SSTI. None of the 
respondents mentioned learning about SSTI prior to experiencing them from services such as NSP. 
The awareness of the unacceptable social and physical consequences of SSTI fostered a sense of 
personal responsibility and agency which led to the introduction or improved HR uptake. However, 
when PWID were struggling to inject or when their social environments were compromised there was  
an  increased risk for SSTI and reduced effectiveness of HR. 
 
In general, interventions are needed to enable PWID to exercise personal responsibility and agency 
over preventing and dealing with SSTI while  also addressing the lack of SSTI awareness and 
knowledge, practical injecting difficulties and the risk environment. There is a need to provide advice 
and information, address individual level behaviour change and structural level change. 
 
SSTI advice could include the signs and symptoms, wound care, HR and sources of healthcare. This 
may help some PWID to feel less stigmatised and panicked by SSTI, aid prevention and encourage 
timely healthcare seeking.  Safer injecting advice could include for example, showing PWID how to 
find a vein to avoid missed hits, and should promote injection site rotation and route transition. We 
found that PWID were reluctant to practice HR such as vein care and route transition before or since 
their SSTI. This was because of poor awareness  of injection site rotation, a  lack of viable veins, a 
reluctance to use alternative injection sites that cannot be concealed, and a preference for injecting 
over other consumption routes. Pragmatic vein care advice has been advocated for PWID having 
difficulty injecting (Harris & Rhodes, 2012). Vein care advice may be more effective for those PWID 
disenfranchised with route transition advice (Harris & Rhodes, 2012). Our findings show that some 
PWID did not consider route transition viable and the few PWID who transitioned to smoking/snorting 
did so either temporarily to allow SSTI  wound  healing or their reason was unrelated to preventing 
SSTI. 
 
Such awareness raising may be needed for all PWID regardless of duration of injecting. In our 
sample, poor knowledge of  SSTI was not necessarily associated  with new initiates to injecting. Our 
PWID had been injecting for on average 15 years, with none having a duration of injecting of less than 
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five years, and some were experiencing their first ever SSTI after five years injecting. This may 
indicate a group of PWID for whom their first SSTI was a consequence of prolonged injecting 
histories, for example, from venous damage. 
 
Our findings also suggest that any HR interventions which focus on the unacceptable consequences 
of SSTI, including the stigma, unsightly visible marks, swellings and pain, rather than health promotion 
may be effective. This is supported by previous work that found body image management, namely 
avoiding track marks and scarring, was a rationale given by HCV negative PWID for engaging with 
HR rather than HCV prevention or vein maintenance (Harris, Treloar, & Maher, 2012). 
 
However, behavioural and individual level HR interventions and messages may be limited in 
effectiveness without a recognition of the limitations imposed by the risk environment (Moore, 2004). 
Interventions also need to address the compromised social, physical and political environments (Tim 
Rhodes, 2002, 2009) exposing PWID to i) injecting equipment shortages, ii) squalid injecting 
environments, iii) withdrawal and iv) adulterated drugs. These experiences, alongside struggling to 
inject, underpin the risk behaviours and compromised HR practices putting PWID at risk of SSTI. 
Consistent with findings from other studies which examined SSTI and injecting (Phillips et al., 2012) or 
injecting in general (Moore, 2004; Neale,  2002; Taylor A., Fleming A., Rutherford J., & Goldberg, 
2004) the PWID in our study were re-using N/S, injecting sub-cutaneously or intra-muscularly, 
inexpertly groin injecting, reliant on assisted injecting and not consistently swabbing. These 
behaviours have been found to be risk factors for SSTI  (Dunleavy et al., 2017; Hope, Hickman, Parry, 
& Ncube, 2014; Hope, Kimber, Vickerman, Hickman, & Ncube, 2008; Larney et al., 2017; Lloyd-Smith 
et al., 2008; Murphy et al., 2001) . 
 
‘Safer environment interventions’ have been identified as mitigating against the risk environment and 
include peer-based harm reduction interventions, NSP provision and supervised injection facilities 
(McNeil & Small, 2014; T. Rhodes et al., 2006) . They produce social, structural and physical settings 
for HR whilst providing access to social and material resources, such as advice, injecting equipment 
supplies and healthcare. 
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Peer based support interventions 
 
There are many examples of peer-based interventions that have provided HR, advice and health 
services (Marshall, Dechman, Minichiello, Alcock, & Harris, 2015). Abscess management, among 
other injecting related harms, has been facilitated through the provision of peer-to-peer out-reach 
education and assistance to promote safer injection techniques at the point of injection (Small et al., 
2012). This has been delivered to those engaged in public or semi-public injecting via drug-user-led  
‘Injection Support Teams’. The advice provided included injection techniques, safer injection 
practices, route transition advice and verbal instruction promoting self- administration of injections. 
However, peer interaction needs to be frequent, for example Jain et al. (2014) found that three or 
more sessions per month were associated with behaviour change such as reduced N/S sharing (Jain 
et al., 2014). Other means of delivering advice and education are needed for PWID not engaged   in 
public injecting. The ‘Injection Support Teams’ also provided peer-led workshops including education 
on bacterial infections from drop-in centres and single room occupancy hotels (Callon, Charles, 
Alexander, Small, & Kerr, 2013). 
 
Structural interventions 
 
Structural level interventions, such as improved NSP provision and medically supervised injecting 
facilities should also be considered for prevention of SSTI. In order to ensure adequate individual-
level N/S coverage, to prevent N/S re-use, policies governing injecting equipment distribution may 
need to be scaled up. Homelessness and public injecting have been found to be associated with a 
‘syringe gap’, that is, an inadequate number of N/S for the number of injections (Bluthenthal, 
Anderson, Flynn, & Kral, 2007; Heller, Paone, Siegler, & Karpati, 2009).  This suggests a need to 
scale-up street based outreach or peer distribution, and 24 hour NSP access. In addition, PWID could 
also be offered a postal service where practical (European Monitoring Centre for Drugs and Drug 
Addiction, 2016). However, expansion of injecting equipment distribution without also offering a more 
client- tailored NSP service that addresses PWID social disadvantages, poor physical and mental 
health will not eliminate risky injecting practices (Treloar, Mao, & Wilson, 2016). 
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Medically supervised injecting facilities could also be instrumental in raising awareness and helping 
PWID avoid SSTI. Although there is no evidence on the  impact of supervised injecting facilities on the 
prevalence and incidence of SSTI, it has been perceived by healthcare staff and users that safer 
injecting education delivered within a supervised injecting facility had resulted in a reduction in 
abscess occurrence (Fast, Small, Wood, & Kerr, 2008; Krüsi, Small, Wood, & Kerr, 2009). Education 
included how to find a vein, tourniquet use, hygienic use of a filter (Wood et al., 2008). In addition, the 
facility was found to increase access to nurses offering SSTI assessment and healthcare and 
facilitated timely hospital referral for the more serious SSTI (Lloyd-Smith et al., 2009; Wood et al., 
2008). It was not the safer injecting education per se but it’s timely delivery within the supportive 
environment of a supervised injecting facility that heightened PWID awareness and diligence, and 
enabled safer injecting to become habit forming both onsite and outside the  supervised injecting 
facility (Fast et al., 2008). Furthermore, the more hygienic space of a supervised injecting facility 
coupled with access to a readily available supply of sterile N/S at the point of injection may for some 
PWID mitigate against physical risk environments. 
 
Although there were no differences in the PWID views and experiences across the two recruitment 
sites SSTI associated with NPS injecting was only experienced within NHS Lothian. NPS 
(ethylphenidate) injecting was more prevalent in NHS Lothian and had been implicated in an outbreak 
of bacterial infections, including SSTI (Lafferty, Smith, Coull, & Shanley, 2016). This highlights a need 
for localised drug-specific as well as general HR advice. For example, drug-specific advice was 
needed for the NPS injectors as the process of drug preparation for injecting ethylphenidate is 
different from heroin (for example, there is no need to heat the drug solution or to use citric acid). 
 
There are a number of limitations with the study. As in all qualitative studies, our sample was small 
and the findings cannot be generalised to other settings. Our participants were drawn from a drug 
treatment and a NSP service, one of which provided a wound clinic. This may have heightened some 
participants’ willingness to engage with HR since their SSTI. In addition, our study did not include 
PWID without experiences of SSTI – this group may have avoided SSTI by increased awareness and 
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HR implementation. 
 
Implications for research, policy and practice 
 
Further research is needed to assess the impact of NPS injecting on HR.  Our findings also highlight 
the compounding effects of drugs as illustrated by the use of NPS. NPS injection has been associated 
with SSTI (Dorairaj, Healy, McMenamin, & Eadie, 2012; Health Protection Scotland & NHS NSS, 
2015; Van Hout & Bingham, 2012). Our findings add to this by suggesting previously adhered to HR 
may be being abandoned when injecting NPS – as highlighted by the sharing of N/S and the squalid 
physical injecting environments. The mechanisms for this are unclear, whether it is a product of the 
social environment, such as the peer group norms of the injecting scene, and/or the psychoactive 
effect of NPS. 
 
Compared to HCV and HIV, SSTI as an injecting related harm has received less policy attention. This 
may in part help to explain the limited learning or awareness about SSTI until experienced first-hand. 
This coupled with the stigma associated with SSTI highlighted a need for awareness raising and 
sharing of SSTI experiences. Our findings also show that PWID experience constraints within their 
physical and social environments that influence their injecting experiences and disrupt HR practices 
increasing their risk of SSTI. Consequently, policy makers need to address SSTI HR within enabling 
environments, such as ‘safer environment interventions’. It is recommended that peer based support, 
improved NSP provision and medically supervised injecting facilities are needed to deliver SSTI HR. 
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